- Home
- ADAM vs EBS Comparison
ADAM vs EBS Comparison
Compare ADAM & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAM | EBS |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.9M | 625.0M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ADAM | EBS |
|---|---|---|
| Price | $7.48 | $11.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.50 | ★ $15.00 |
| AVG Volume (30 Days) | 578.8K | ★ 871.0K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | ★ 12.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.19 | ★ 1.35 |
| Revenue | $216,781,000.00 | ★ $788,900,000.00 |
| Revenue This Year | $13.60 | N/A |
| Revenue Next Year | $49.42 | $15.21 |
| P/E Ratio | $38.51 | ★ $8.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.02 | $4.02 |
| 52 Week High | $7.75 | $13.41 |
Technical Indicators
Market Signals| Indicator | ADAM | EBS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 62.23 |
| Support Level | N/A | $10.63 |
| Resistance Level | N/A | $12.28 |
| Average True Range (ATR) | 0.00 | 0.59 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 0.00 | 86.96 |
Price Performance
Historical ComparisonAbout ADAM Adamas Trust Inc. Common Stock
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing and managing primarily mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit sensitive single-family and multi-family assets.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.